Qiagen NV - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
QGEN New York 2836 https://www.qiagen.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Qiagen NV

Here’s What Hedge Funds Think About Qiagen NV (QGEN) - Jun 13th, 2019 5:37 pm
Here's Why You Should Hold on to QIAGEN (QGEN) Stock Now - Jun 11th, 2019 7:22 am
See what the IHS Markit Score report has to say about Qiagen NV. - Jun 10th, 2019 6:07 am
QIAGEN-DiaSorin Union to Enhance QuantFERON for Lyme Disease - Jun 6th, 2019 7:58 am
Qiagen (QGEN) Up 4% Since Last Earnings Report: Can It Continue? - Jun 5th, 2019 7:30 am
QIAGEN and DiaSorin collaborate on novel QuantiFERON-based test with breakthrough potential for earlier detection of Lyme disease - Jun 4th, 2019 11:30 pm
At US$37.76, Is It Time To Put QIAGEN N.V. (NYSE:QGEN) On Your Watch List? - May 30th, 2019 8:52 am
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? - May 30th, 2019 4:53 am
QIAGEN (QGEN) Launches PIK3CA Kit for Breast Cancer Patients - May 28th, 2019 7:09 am
QIAGEN launches first FDA-approved companion diagnostic for PIK3CA biomarkers to enhance precision medicine in breast cancer - May 24th, 2019 2:52 pm
QIAGEN (QGEN) to Win U. N. Accolade for QuantiFERON-TB Access - May 23rd, 2019 6:25 am
QIAGEN’s QuantiFERON®-TB Access development program gains recognition from United Nations initiative for health innovation - May 21st, 2019 2:05 pm
Sprint and Qiagen rise while Apple and Dish decline - May 20th, 2019 2:30 pm
Qiagen Snags FDA Nod For Molecular Diagnostic System, Announces US Launch - May 20th, 2019 8:53 am
QIAGEN Partners Inovio to Develop Companion Diagnostics - May 17th, 2019 9:53 am
The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering - May 17th, 2019 6:03 am
Inovio and QIAGEN Establish Collaboration to Develop Diagnostic Test for VGX-3100, Inovio's Novel Immunotherapy Targeting Advanced Cervical Pre-Cancer - May 16th, 2019 2:02 pm
QIAGEN and Inovio Collaborate to Develop Companion Diagnostic for Novel Immunotherapy Targeting Precancerous Cervical Lesions - May 16th, 2019 2:02 pm